In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study.
Francesco PepeElena Guerini-RoccoMatteo FassanNicola FuscoDavide VacircaAlberto RanghieroKonstantinos VenetisAlessandra RappaSergio Vincenzo TaorminaGianluca RussoElena RebellatoGiada MunariAndrea Moreno-ManuelCarmine De AngelisClaudio ZamagniGiorgio ValabregaUmberto MalapelleGiancarlo TronconeMassimo BarberisAntonino IaccarinoPublished in: Journal of clinical pathology (2023)
In-house testing for HRD can be reliably performed with commercially available next-generation sequencing assays.